An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs

scientific article

An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/AJE/KWQ008
P932PMC publication ID2850972
P698PubMed publication ID20219765
P5875ResearchGate publication ID41894488

P50authorSten VermundQ42891634
Andrew O WestfallQ44237002
Benjamin H ChiQ90251061
Jeffrey S. A. StringerQ90251064
P2093author name stringAlbert Mwango
Wilbroad Mutale
Ronald A Cantrell
Mohammed Limbada
Lloyd B Mulenga
P2860cites workSimple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapyQ37355638
A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, ZambiaQ37357749
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in ZambiaQ42635298
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesQ46391119
Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, ZambiaQ46909093
The unseen sample in cohort studies: estimation of its size and effect. Multicenter AIDS Cohort StudyQ47421718
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.Q51809092
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.Q53645693
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohortQ83323867
Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewQ33302944
Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: a comparison of five different methodsQ33320348
Development of mental health first aid guidelines for suicidal ideation and behaviour: a Delphi studyQ33325659
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settingsQ33399742
Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.Q33460434
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomesQ34556854
Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in AfricaQ37012911
True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in MalawiQ37084876
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countriesQ37108925
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, ZambiaQ37113579
Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, ZambiaQ37209897
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaQ37265947
CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, ZambiaQ37325907
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapineQ37351372
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectanti-retroviral agentQ50430310
P304page(s)924-931
P577publication date2010-03-10
P1433published inAmerican Journal of EpidemiologyQ4744243
P1476titleAn empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs
P478volume171

Reverse relations

cites work (P2860)
Q39838561A Prospective Cohort Study of Intimate Partner Violence and Unprotected Sex in HIV-Positive Female Sex Workers in Mombasa, Kenya
Q39553800A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort
Q39989882A risk score to identify HIV-infected women most likely to become lost to follow-up in the postpartum period
Q33803726A simple novel method for determining mortality rates in HIV treatment programs worldwide
Q33770158Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa
Q34266281Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia
Q33867894Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti
Q36301925Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa
Q24630559Combination prevention: new hope for stopping the epidemic
Q35549179Comparative outcomes of tenofovir-based and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia
Q34672929Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?
Q36386776Does provider-initiated counselling and testing (PITC) strengthen early diagnosis and treatment initiation? Results from an analysis of an urban cohort of HIV-positive patients in Lusaka, Zambia
Q34503222Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study
Q35883654Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study
Q34113515Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland
Q38598283Health status, food insecurity, and time allocation patterns of patients with AIDS receiving antiretroviral treatment in South Africa
Q33746982Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system
Q37138868Impact of definitions of loss to follow-up (LTFU) in antiretroviral therapy program evaluation: variation in the definition can have an appreciable impact on estimated proportions of LTFU.
Q37127890Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique
Q40397030Long-term outcomes of antiretroviral therapy in an adult HIV program: a 10-year retrospective cohort study in Kano, Nigeria
Q37136495Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients
Q35810398Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD.
Q34649232Loss to follow-up as a competing risk in an observational study of HIV-1 incidence
Q92758583Loss to follow-up from antiretroviral therapy clinics: A systematic review and meta-analysis of published studies in South Africa from 2011 to 2015
Q37256464Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study
Q37262727Mortality and loss to follow-up in the first year of ART: Malawi national ART programme
Q36708737Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa.
Q39013116Patient engagement in HIV care and treatment in Zambia, 2004-2014.
Q36928000Predictors of patient attrition according to different definitions for loss to follow-up: a comparative analysis from Lusaka, Zambia
Q36670625Premature adult mortality in urban Zambia: a repeated population-based cross-sectional study
Q90022761Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania
Q57999164Response to: defaulting from antiretroviral treatment programmes in sub-Saharan Africa: a problem of definition
Q37368956Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar
Q39283671Sex disparities in outcomes among adults on long-term antiretroviral treatment in northern Nigeria.
Q37460044Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia
Q36010200Survival functions for defining a clinical management Lost To Follow-Up (LTFU) cut-off in Antiretroviral Therapy (ART) program in Zomba, Malawi.
Q34399340Trends in all-cause mortality during the scale-up of an antiretroviral therapy programme: a cross-sectional study in Lusaka, Zambia
Q34996955Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics
Q30491997Underutilisation of routinely collected data in the HIV programme in Zambia: a review of quantitatively analysed peer-reviewed articles
Q34062163Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America

Search more.